Murphy, B E Pearson, Abbott, F V, Allison, C M et al. · Psychoneuroendocrinology · 2004 · DOI
Researchers measured hormone breakdown products in the blood of women with ME/CFS and compared them to healthy women. They found that women with ME/CFS had significantly higher levels of a specific progesterone metabolite called isopregnanolone—more than twice as high as controls. This suggests that abnormal hormone metabolism may be involved in ME/CFS, and that depression alone cannot explain these chemical differences.
This study provides biochemical evidence for a distinctive neuroendocrine abnormality in ME/CFS that is not simply secondary to depression, potentially opening new avenues for understanding disease mechanisms. Identifying specific metabolic markers like isopregnanolone could eventually aid in diagnosis and lead to targeted therapeutic interventions addressing progesterone metabolism.
This study demonstrates association, not causation—elevated isopregnanolone may be a consequence of ME/CFS rather than a cause. The small sample size and cross-sectional design prevent conclusions about whether these metabolites change over time or predict disease progression. The study also does not establish whether these metabolic differences contribute to symptom pathogenesis or are epiphenomena.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →